|
|
||||||||
Gastrointestinal Imaging |
1 From the Departments of Radiology (A.R.v.E., M.E.J.P., A.A.v.d.B.H., M.N.J.M.W., J.L.B.) and Oncological Surgery (C.J.H.v.d.V.), Leiden University Medical Center, Albinusdreef 2, PO Box 9600, 2300 RC Leiden, the Netherlands. Received August 3, 2001; revision requested September 10; revision received November 14; accepted January 7, 2002. M.E.J.P. supported by the Dutch Cancer Foundation, with a grant for work on the detection of hepatic metastases in patients with colorectal cancer. Address correspondence to A.R.v.E. (e-mail: a.r.van_erkel@lumc.nl).
PURPOSE: To determine the relationship between the size of hepatic metastases, the standard of reference, and the reported detection rate in patients with colorectal cancer.
MATERIALS AND METHODS: With use of a MEDLINE search (January 1994 to January 2001), articles were selected that contained original results on detection of hepatic metastases of colorectal cancer, categorized for size in at least two categories, with use of helical computed tomography (CT), helical CT at arterial portography, or magnetic resonance imaging. Results were compared with the size distribution of hepatic metastases in 47 consecutive patients with colorectal carcinoma, which were detected by using a combination of intraoperative ultrasonography (US) and palpation.
RESULTS: Seven studies met all predefined criteria. Four studies involved intraoperative US in all patients and demonstrated a significant negative correlation (-0.988) between detection rate and fraction of small metastases. These studies had a higher fraction and lower detection rate of small metastases and a lower overall detection rate. A majority (58% [145 of 252]) of metastases in the study population were smaller than 20 mm.
CONCLUSION: Few articles adequately describe the standard of reference and size distribution of hepatic lesions. Hepatic metastases of colorectal cancer are frequently smaller than 20 mm. When the standard of reference is suboptimal, many small metastases are excluded from analysis, and detection rates are therefore inflated.
© RSNA, 2002
Index terms: Colon, CT, 75.12115, 75.12119 Colon, MR, 75.1214 Colon, US, 75.12982 Colon neoplasms, 75.321 Liver neoplasms, metastases, 761.332 Technology assessment
This article has been cited by other articles:
![]() |
H. J. Kim, K. W. Kim, J. H. Byun, H. J. Won, Y. M. Shin, P. N. Kim, M.-S. Lee, and M.-G. Lee Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. Am. J. Roentgenol., April 1, 2006; 186(4): 1059 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kim, A. Y. Kim, T. K. Kim, S. H. Park, H. J. Kim, Y. K. Lee, M.-S. Park, H. K. Ha, P. N. Kim, J. C. Kim, et al. Small (l.e. 2cm) Hepatic Lesions in Colorectal Cancer Patients: Detection and Characterization on Mangafodipir Trisodium-Enhanced MRI Am. J. Roentgenol., May 1, 2004; 182(5): 1233 - 1240. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |